|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2006-11-7
|
|
pubmed:abstractText |
To investigate the pattern of regional cerebral blood flow (rCBF) deficits in Parkinson's disease patients in relation to cognitive decline and to assess the clinical usefulness of single photon emission tomography (SPET) scanning in differentiation between Parkinson's disease patients with dementia and those without cognitive deficits.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0143-3636
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
945-51
|
|
pubmed:meshHeading |
pubmed-meshheading:17088679-Aged,
pubmed-meshheading:17088679-Aged, 80 and over,
pubmed-meshheading:17088679-Brain,
pubmed-meshheading:17088679-Cerebrovascular Circulation,
pubmed-meshheading:17088679-Cognition Disorders,
pubmed-meshheading:17088679-Cysteine,
pubmed-meshheading:17088679-Female,
pubmed-meshheading:17088679-Humans,
pubmed-meshheading:17088679-Male,
pubmed-meshheading:17088679-Middle Aged,
pubmed-meshheading:17088679-Organotechnetium Compounds,
pubmed-meshheading:17088679-Parkinson Disease,
pubmed-meshheading:17088679-Prognosis,
pubmed-meshheading:17088679-Radiopharmaceuticals,
pubmed-meshheading:17088679-Reproducibility of Results,
pubmed-meshheading:17088679-Sensitivity and Specificity,
pubmed-meshheading:17088679-Tomography, Emission-Computed, Single-Photon
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.
|
|
pubmed:affiliation |
Neurophysiology Department, Institute of Psychiatry and Neurology, Warsaw, Poland. mderejko@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Evaluation Studies
|
